Price$20.56-5.89 (-22.27%)
2026-03-042026-06-05
News · 26 weeks46-64%
2025-12-142026-06-07
Mix2690d
- Analyst8(31%)
- Insider7(27%)
- Other6(23%)
- SEC Filings4(15%)
- Earnings1(4%)
Latest news
25 items- PRDoximity to Present at the William Blair 46th Annual Growth Stock ConferenceDoximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced that Jeff Tangney, co-founder and CEO, will present at the William Blair 46th Annual Growth Stock Conference on Tuesday, June 2, 2026 at 4:40 p.m. Central Time. About Doximity Founded in 2010, Doximity is the leading digital platform for U.S. medical professionals. The company's network members include more than 85% of U.S. physicians across all specialties and practice areas. Doximity provides its verified clinical membership with digital tools built for medicine, enabling them to collaborate with colleagues, stay current on medical news and research, manage their careers and on-cal
- INSIDERInterim PFO and PAO Sitaram Siddharth covered exercise/tax liability with 1,246 shares, decreasing direct ownership by 1% to 88,150 units (SEC Form 4) (tax liability)4 - Doximity, Inc. (0001516513) (Issuer)
- INSIDERChief Executive Officer Tangney Jeffrey was granted 322,614 shares and covered exercise/tax liability with 14,964 shares, increasing direct ownership by 14% to 2,540,460 units (SEC Form 4) to satisfy tax liability4 - Doximity, Inc. (0001516513) (Issuer)
- SECSEC Form S-8 filed by Doximity Inc.S-8 - Doximity, Inc. (0001516513) (Filer)
- SECSEC Form 10-K filed by Doximity Inc.10-K - Doximity, Inc. (0001516513) (Filer)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Doximity Inc.SCHEDULE 13G/A - Doximity, Inc. (0001516513) (Subject)
- ANALYSTDoximity downgraded by Barclays with a new price targetBarclays downgraded Doximity from Overweight to Equal Weight and set a new price target of $20.00
- ANALYSTDoximity downgraded by KeyBanc Capital MarketsKeyBanc Capital Markets downgraded Doximity from Overweight to Sector Weight
- ANALYSTDoximity downgraded by Robert W. Baird with a new price targetRobert W. Baird downgraded Doximity from Outperform to Neutral and set a new price target of $18.00
- ANALYSTDoximity downgraded by BTIG ResearchBTIG Research downgraded Doximity from Buy to Neutral
- ANALYSTDoximity downgraded by Jefferies with a new price targetJefferies downgraded Doximity from Buy to Hold and set a new price target of $19.00
- ANALYSTDoximity downgraded by Wells Fargo with a new price targetWells Fargo downgraded Doximity from Overweight to Equal Weight and set a new price target of $18.00
- INSIDERInterim PFO and PAO Sitaram Siddharth converted options into 5,000 shares and sold $59,503 worth of shares (2,309 units at $25.77) as part of a pre-agreed trading plan, increasing direct ownership by 3% to 89,396 units (SEC Form 4) (withholding obligation)4 - Doximity, Inc. (0001516513) (Issuer)
- SECDoximity Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Leadership Update, Financial Statements and Exhibits8-K - Doximity, Inc. (0001516513) (Filer)
- PRDoximity Partners with Aledade to Bring Clinical AI to Value-Based Care SettingsDoximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced an integration with Aledade, a physician‑led, national leader in value‑based care. Through the agreement, Doximity will integrate components of its HIPAA-compliant Clinical AI Suite, including its ambient notetaking tool Scribe and clinical AI assistant Ask (formerly DoxGPT), into Aledade Assist™, Aledade's EHR overlay that surfaces clinical insights at the point of care. "We're proud to partner with Aledade to support independent physicians with customizable AI solutions to help them save time and money," said Jeff Tangney, co-founder and CEO of Doximity. Scribe will serve as an amb
- INSIDERDirector Wampler Kira Scherer converted options into 9,000 shares and sold $234,540 worth of shares (9,000 units at $26.06) as part of a pre-agreed trading plan (SEC Form 4)4 - Doximity, Inc. (0001516513) (Issuer)
- SECSEC Form SCHEDULE 13G filed by Doximity Inc.SCHEDULE 13G - Doximity, Inc. (0001516513) (Subject)
- PRDoximity to Release Fiscal 2026 Fourth Quarter and Full Year Results on May 13, 2026Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal fourth quarter and full year ended March 31, 2026 after market close on May 13, 2026. Doximity will host a conference call and webcast at 2:00 p.m. PT (5:00 p.m. ET) to discuss the financial results. To listen to a live audio webcast, please visit the Company's Investor Relations page at https://investors.doximity.com/ before the call. A webcast replay will be available on the website following the call. About Doximity Founded in 2010, Doximity is the leading digital platform for U.S. medical professionals. The company's network membe
- ANALYSTDoximity downgraded by Truist with a new price targetTruist downgraded Doximity from Buy to Hold and set a new price target of $29.00
- SECDoximity Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure8-K - Doximity, Inc. (0001516513) (Filer)
- INSIDERSEC Form 4 filed by Sitaram Siddharth4 - Doximity, Inc. (0001516513) (Issuer)
- ANALYSTDoximity downgraded by Evercore ISI with a new price targetEvercore ISI downgraded Doximity from Outperform to In-line and set a new price target of $25.00
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Doximity Inc.SCHEDULE 13G/A - Doximity, Inc. (0001516513) (Subject)
- PRDoximity Study Finds Physicians Rapidly Adopting AI, But Accuracy Concerns Persist94% of physicians are using AI or interested, but 71% are concerned about its accuracy and reliability Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today released a new report examining how physicians are adopting artificial intelligence (AI) in clinical practice. The findings show that AI adoption and interest are widespread: 94% of physicians reported they are currently using AI or interested in doing so. At the same time, physicians remain cautious, with 71% citing accuracy and reliability as their top concern. "AI has quickly become a meaningful part of physicians' daily workflows," said Amit Phull, MD, chief clinical experience officer at
- INSIDERInterim PFO and PAO Sitaram Siddharth converted options into 5,000 shares and sold $58,833 worth of shares (2,319 units at $25.37), increasing direct ownership by 3% to 84,132 units (SEC Form 4)4 - Doximity, Inc. (0001516513) (Issuer)
DOCS FAQ
6 questionsWhere does DOCS stock trade?
Doximity Inc. (DOCS) is listed on NYSE.What sector and industry is DOCS in?
Doximity Inc. operates in the Technology sector, EDP Services industry.When did Doximity Inc. go public?
Doximity Inc. (DOCS) completed its IPO in 2021.What are analysts saying about DOCS?
Doximity Inc. has had 8 recent analyst actions on file. The most recent action was from Barclays: Equal Weight with a $2000.00 price target on 2026-05-15. Recent price targets range from $1800.00 to $2900.00.What companies are similar to DOCS?
Notable peers in the same industry include NEE (NextEra Energy Inc.), PDD (PDD Holdings Inc.), INFY (Infosys Limited), WDAY (Workday Inc.), DASH (DoorDash Inc.). Compare DOCS side-by-side with any of them on Quantisnow.How can I track DOCS on Quantisnow?
Quantisnow aggregates Doximity Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow DOCS to receive live email and push alerts on every new disclosure.